Genomic events contributing to the high prevalence of amantadine-resistant influenza A/H3N2

Antiviral Therapy

Volumn 15, Issue 3, 2010, Pages 307-319

  Zaraket, Hassan ^a   Saito, Reiko ^a   Suzuki, Yasushi ^a   Suzuki, Yoshiyuki ^b   Caperig Dapat, Isolde ^a   Dapat, Clyde ^a   Shabana, Iman I ^a   Baranovich, Tatiana ^a   Suzuki, Hiroshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF GENETICS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMINO ACID; PROTEIN M2; ANTIVIRUS AGENT;

ANTIGENIC VARIATION; ARTICLE; CLADISTICS; CONTROLLED STUDY; GENE SEQUENCE; HUMAN; INFLUENZA VIRUS A H3N2; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; VIRUS GENOME; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION; ANTIVIRAL RESISTANCE; DNA SEQUENCE; DRUG EFFECTS; GENETIC RECOMBINATION; GENETICS; INFLUENZA, HUMAN; JAPAN; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; SEASON; VIROLOGY;

AMANTADINE; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; GENOME, VIRAL; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; JAPAN; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PREVALENCE; RECOMBINATION, GENETIC; SEASONS; SEQUENCE ANALYSIS, DNA;

EID: 77952949710     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1538     Document Type: Article

References (33)

1. Barr IG, Hurt AC, Deed N, Iannello P, Tomasov C, Komadina N. The emergence of adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006. Antiviral Res 2007; 75:173-176. (Pubitemid 46669706)
2. Deyde VM, Xu X, Bright RA, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007; 196:249-257. (Pubitemid 47047464)
3. Bright RA, Medina MJ, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005; 366:1175-1181. (Pubitemid 41393595)
4. Hayden FG. Antiviral resistance in influenza viruses - implications for management and pandemic response. N Engl J Med 2006; 354:785-788.
5. Saito R, Li D, Shimomura C, et al. An off-seasonal amantadine-resistant H3N2 influenza outbreak in Japan. Tohoku J Exp Med 2006; 210:21-27. (Pubitemid 44377785)
6. Saito R, Li D, Suzuki H. Amantadine-resistant influenza A (H3N2) virus in Japan, 2005-2006. N Engl J Med 2007; 356:312-313.
7. Saito R, Li D, Suzuki Y, et al. High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season. J Med Virol 2007; 79:1569-1576. (Pubitemid 47328746)
8. Saito R, Suzuki Y, Li D, et al. Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan. J Infect Dis 2008; 197:630-632. (Pubitemid 351321543)
9. Suzuki Y, Taira K, Saito R, et al. Epidemiologic study of influenza infection in Okinawa, Japan, from 2001 to 2007: changing patterns of seasonality and prevalence of amantadine-resistant influenza A virus. J Clin Microbiol 2009; 47:623-629.
10. Zaraket H, Saito R, Sato I, et al. Molecular evolution of human influenza A viruses in a local area during eight influenza epidemics from 2000 to 2007. Arch Virol 2009; 154:285-295.
11. Simonsen L, Viboud C, Grenfell BT, et al. The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol 2007; 24:1811-1820. (Pubitemid 47236702)
12. Li D, Saito R, Suzuki Y, et al. In vivo and in vitro alterations in influenza A/H3N2 virus M2 and hemagglutinin genes: effect of passage in MDCK-SIAT1 cells and conventional MDCK cells. J Clin Microbiol 2009; 47:466-468.
13. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 2001; 146:2275-2289. (Pubitemid 34682391)
14. Ghedin E, Sengamalay NA, Shumway M, et al. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 2005; 437:1162-1166.
15. Bao Y, Bolotov P, Dernovoy D, et al. The influenza virus resource at the National Center for Biotechnology Information. J Virol 2008; 82:596-601.
16. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp 1999; 41:95-98.
17. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-1599. (Pubitemid 47236692)
18. Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003; 52:696-704. (Pubitemid 37365050)
19. Holmes, EC, Ghedin N, Miller J, et al. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol 2005; 3:e300.
20. Li D, Saito R, Le MT, et al. Genetic analysis of influenza A/H3N2 and A/H1N1 viruses circulating in Vietnam from 2001 to 2006. J Clin Microbiol 2008; 46:399-405.
21. Nelson MI, Edelman L, Spiro DJ, et al. Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States. PLoS Pathog 2008; 4:e1000133.
22. Furuse Y, Suzuki A, Kamigaki T, Shimizu M, Fuji N, Oshitani H. Reversion of influenza A (H3N2) from amantadine-resistant to amantadine-sensitive by further reassortment in Japan during the 2006-2007 influenza season. J Clin Microbiol 2009; 47:841-844.
23. Hay AJ, Zambon MC, Wolstenholme AJ, Skehel JJ, Smith MH. Molecular basis of resistance of influenza A viruses to amantadine. J Antimicrob Chemother 1986; 18 Suppl B:19-29.
24. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. The molecular basis of the specific anti-influenza action of amantadine. EMBO J 1985; 4:3021-3024.
25. Abed Y, Goyette N, Boivin G. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob Agents Chemother 2005; 49:556-559. (Pubitemid 40175661)
26. Sweet C, Hayden FG, Jakeman KJ, Grambas S, Hay AJ. Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets. J Infect Dis 1991; 164:969-972.
27. Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989; 321:1696-1702. (Pubitemid 20020544)
28. Saito R, Oshitani H, Masuda H, Suzuki H. Detection of amantadine-resistant influenza A virus strains in nursing homes by PCR-restriction fragment length polymorphism analysis with nasopharyngeal swabs. J Clin Microbiol 2002; 40:84-88. (Pubitemid 34027605)
29. Suzuki H, Saito R, Masuda H, Oshitani H, Sato M, Sato I. Emergence of amantadine-resistant influenza A viruses: epidemiological study. J Infect Chemother 2003; 9:195-200. (Pubitemid 37288281)
30. Hayden FG, Hay AJ. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr Top Microbiol Immunol 1992; 176:119-130.
31. Stilianakis NI, Perelson AS, Hayden FG. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model. J Infect Dis 1998; 177:863-873.
32. Chen W, Calvo PA, Malide D, et al. A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 2001; 7:1306-1312.
33. Wang W, Riedel K, Lynch P, Chien CY, Montelione GT, Krug RM. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 1999; 5:195-205. (Pubitemid 29079280)